AstraZenecaAstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit:

AstraZeneca RSS Channel

Title Filter      Display #  
# Article Title
1 AstraZeneca and MRC enter strategic collaboration
2 MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
3 FDA Advisory Committee votes on investigational medicine metreleptin
4 AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex
5 AstraZeneca advances MedImmune's benralizumab to Phase III in severe asthma
6 AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability
7 AstraZeneca enters co-promotion agreement with Janssen in Japan for innovative prostate cancer treatment
8 AstraZeneca and Merck enter licence agreement for investigational oral WEE1 kinase inhibitor therapy for cancer
9 MedImmune strengthens immune-mediated cancer therapy portfolio with acquisition of Amplimmune
10 AstraZeneca PLC second quarter and half year results 2013
11 AstraZeneca and Bristol-Myers Squibb resubmit dapagliflozin New Drug Application
12 AstraZeneca collaborates with Cambridge medical research institutions to advance cancer research
13 AstraZeneca selects location for new global R&D centre and corporate headquarters
14 MedImmune, AstraZeneca's biologics arm, and NGM Biopharmaceuticals announce agreement to discover and develop therapies for diabetes and obesity
15 AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
16 AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio
17 AstraZeneca issues update on accelerated oncology pipeline
18 AstraZeneca first quarter results 2013
19 MedImmune, AstraZeneca's biologics unit, acquires AlphaCore Pharma
20 AstraZeneca settles litigation over CRESTOR patent
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]